Sign in

CIK 0001509261 · Non-accelerated filer<br>Smaller reporting company

Rezolute, Inc.

Sign in to watch
Ticker
RZLT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Jun 30
Incorporated
NV
Entity type
operating
EIN
273440894
Phone
650-206-4507
Business address
275 SHORELINE DRIVE, SUITE 500, REDWOOD CITY, CA, 94065
Former names
AntriaBio, Inc., FITS MY STYLE INC
  1. SCHEDULE 13G Stake Statement of Beneficial Ownership
  2. SCHEDULE 13G Stake Statement of Beneficial Ownership
  3. 4 Open-market buy Director bought 5,650 shares at $1.69 ($9,549)
  4. 4 Open-market buy Chief Medical Officer bought 28,000 shares at $1.70 ($47,600)
  5. 4 Open-market buy CFO bought 45,000 shares at an average $1.77 ($79,578)
  6. 4 Open-market buy CEO bought 32,000 shares at $1.59 ($50,880)
  7. 4 Open-market buy Chief Commercial Officer bought 12,100 shares at an average $1.62 ($19,599)
  8. S-3ASR Offering Registration Statement
  9. 4 Grant or award Chief Medical Officer acquired 123,000 shares (grant or award)
  10. 4 Grant or award Chief Commercial Officer acquired 32,000 shares (grant or award)
  11. 4 Grant or award CEO acquired 317,000 shares (grant or award)
  12. 4 Grant or award CFO acquired 107,000 shares (grant or award)
  13. S-8 Other Securities Offered to Employees in Benefit Plans
  14. 4 Grant or award Director acquired 21,000 shares (grant or award)
  15. 4 Grant or award Director acquired 21,000 shares (grant or award)
  16. 4 Grant or award Director acquired 21,000 shares (grant or award)
  17. 8-K Event Shareholder vote results
  18. 4 Grant or award Director acquired 21,000 shares (grant or award)
  19. 4 Grant or award Director acquired 21,000 shares (grant or award)
  20. 4 Grant or award Director acquired 21,000 shares (grant or award)

Page 3 of 38 · 760 filings